ALEXANDRA COLE: Open Payments
NPI 1376297051 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$942 in 52 payments from 10 companies in 2025. Trend: 2023 $1,062 · 2024 $1,232 · 2025 $942
Food & beverage: $942
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $295 |
| Lundbeck LLC | 12 | $171 |
| E.R. Squibb & Sons, L.L.C. | 7 | $147 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| Neurocrine BioSciences, Inc. | 3 | $65 |
| Vanda Pharmaceuticals Inc. | 3 | $60 |
| Tris Pharma Inc | 1 | $22 |
| Alkermes, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: VRAYLAR, REXULTI, COBENFY, CAPLYTA, INGREZZA, HETLIOZ, FANAPT, Dyanavel XR.
Industry payments across NC — which companies pay providers there.
